Core Laboratories N.V. (CLB) |
| 16.88 -0.19 (-1.11%) 04-14 10:49 |
| Open: | 16.97 |
| High: | 17.06 |
| Low: | 16.56 |
| Volume: | 81,652 |
| Market Cap: | 777(M) |
| PE Ratio: | 26.79 |
| Exchange: | New York Stock Exchange |
| Industry: | Oil & Gas Equipment & Services |
| Sector: | Energy |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 20.87 |
| Resistance 1: | 17.87 |
| Pivot price: | 16.63 |
| Support 1: | 16.28 |
| Support 2: | 15.30 |
| 52w High: | 20.36 |
| 52w Low: | 9.72 |
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
| EPS | 0.630 |
| Book Value | 5.770 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.365 |
| Profit Margin (%) | 5.64 |
| Operating Margin (%) | 10.93 |
| Return on Assets (ttm) | 5.5 |
| Return on Equity (ttm) | 11.6 |
Thu, 09 Apr 2026
Core Laboratories (NYSE:CLB) Updates Q1 2026 Earnings Guidance - MarketBeat
Fri, 03 Apr 2026
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving Average - Here's Why - MarketBeat
Fri, 27 Mar 2026
Core Laboratories (NYSE:CLB) Trading Up 5.5% - Here's Why - MarketBeat
Mon, 23 Mar 2026
CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE - Yahoo Finance
Mon, 23 Mar 2026
Middle East conflict hits Core Lab as project delays cut Q1 outlook - Stock Titan
Fri, 06 Mar 2026
Core Laboratories (CLB) Gains on Sequential Revenue Growth and Solintec Acquisition - Insider Monkey
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |